These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 31391070)
1. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling. Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma. Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962 [TBL] [Abstract][Full Text] [Related]
3. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription. Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495 [TBL] [Abstract][Full Text] [Related]
4. ApoM suppresses kidney renal clear cell carcinoma growth and metastasis via the Hippo-YAP signaling pathway. Xu T; Wei D; Yang Z; Xie S; Yan Z; Chen C; Hu W; Shi Z; Zhao Y; Cui M; Xu Z; Wang J Arch Biochem Biophys; 2023 Jul; 743():109642. PubMed ID: 37211224 [TBL] [Abstract][Full Text] [Related]
5. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics. Wu H; Liu M; He Y; Meng G; Guo W; Guo Q BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726 [TBL] [Abstract][Full Text] [Related]
6. RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma. Li D; Tang L; Liu B; Xu S; Jin M; Bo W Aging (Albany NY); 2021 Mar; 13(7):10450-10467. PubMed ID: 33790054 [No Abstract] [Full Text] [Related]
7. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening. Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208 [TBL] [Abstract][Full Text] [Related]
8. SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway. Yin L; Li W; Xu A; Shi H; Wang K; Yang H; Wang R; Peng B EBioMedicine; 2020 Jan; 51():102596. PubMed ID: 31911271 [TBL] [Abstract][Full Text] [Related]
9. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
10. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma. Xing Q; Ji C; Zhu B; Cong R; Wang Y Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567 [TBL] [Abstract][Full Text] [Related]
11. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma. Chang Y; Li N; Yuan W; Wang G; Wen J Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606 [TBL] [Abstract][Full Text] [Related]
12. miR-138-5p inhibits proliferation and invasion in kidney renal clear cell carcinoma by targeting SINA3 and regulation of the Notch signaling pathway. Liu Y; Qu HC J Clin Lab Anal; 2021 Nov; 35(11):e23766. PubMed ID: 34586647 [TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma. Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma. Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653 [TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling. Ye Y; Zhang F; Chen Q; Huang Z; Li M Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578 [TBL] [Abstract][Full Text] [Related]
16. Autophagy-related gene Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756 [TBL] [Abstract][Full Text] [Related]
17. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification. Zhang Y; Zhang Z; Zhang W; Hu H; Bao G Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397 [TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway. Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137 [TBL] [Abstract][Full Text] [Related]
19. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis. Hu F; Zeng W; Liu X Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630 [TBL] [Abstract][Full Text] [Related]
20. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma. Chen L; Xiang Z; Chen X; Zhu X; Peng X Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]